GEN News Highlights: Feb 2, 2009

National University of Ireland Opens Mass Spec Facility with Agilent Technology

(Page 1 of 1)

    A biological mass spectrometry facility has been set up on the National University of Ireland (NUI), Galway campus. It is equipped with the latest accurate mass quadrupole time-of-flight and triple quadrupole mass spectrometer platforms from Agilent.

    The facility primarily focuses on functional genomics, proteomics, lipidomics, and metabolomics research. As part of the collaboration, NUI Galway will provide application notes and data for key applications using the Agilent Q-TOF and QQQ platforms. The facility will also be used to showcase new instruments to Agilent customers and to run samples for demonstration purposes.

    Work to be conducted here includes research to understand the neurobiology of pain and anxiety, development of novel therapeutic agents for their treatment, and quantitative proteomics.

    The partnership between NUI Galway and Agilent is a result of Agilent’s Academia Program, which facilitates collaborations with universities around the world.

    ---

     


Related content

GEN News Highlights

Insight & Intelligence™

GEN Articles

Application Notes

Webinars

GEN Podcasts

Video Channel

New Products

Best of the Web

GEN Polls

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll